Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with
- PMID: 11156775
- PMCID: PMC7973952
Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with
Abstract
We present a case of pleomorphic xanthoastrocytoma (PXA) in a patient with temporal lobe seizures. Imaging sequences included MR, and results of positron emission tomography (PET) with [18F]-fluorodeoxyglucose (FDG) and [11C]-methionine (Met) tracers revealed a hypermetabolic region equivalent or nearly equivalent to normal cerebral cortex, suggesting that the tumor might have malignant potential. Histopathologic findings indicated low-grade glioma. The mechanism for glucose hypermetabolic activity of PXA is not clear; however, the positive findings obtained from FDG-PET may not always indicate the degree of malignancy associated with PXA.
Figures



Similar articles
-
A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours.Eur J Nucl Med. 1998 Sep;25(9):1261-9. doi: 10.1007/s002590050294. Eur J Nucl Med. 1998. PMID: 9724375
-
PET-FDG of pleomorphic xanthoastrocytoma.J Nucl Med. 1995 Jan;36(1):97-9. J Nucl Med. 1995. PMID: 7799091
-
Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.J Neurol Sci. 2006 Jul 15;246(1-2):85-94. doi: 10.1016/j.jns.2006.02.015. Epub 2006 Mar 6. J Neurol Sci. 2006. PMID: 16603193
-
Positron emission tomography imaging of brain tumors.Neuroimaging Clin N Am. 2002 Nov;12(4):615-26. doi: 10.1016/s1052-5149(02)00033-3. Neuroimaging Clin N Am. 2002. PMID: 12687915 Review.
-
[11C-methionine positron emission tomography in brain tumor].No Shinkei Geka. 2008 Oct;36(10):847-59. No Shinkei Geka. 2008. PMID: 18975560 Review. Japanese. No abstract available.
Cited by
-
Cerebral anaplastic pleomorphic xanthoastrocytoma with meningeal dissemination at first presentation.Childs Nerv Syst. 2004 Feb;20(2):119-22. doi: 10.1007/s00381-003-0854-6. Epub 2003 Dec 11. Childs Nerv Syst. 2004. PMID: 14669022
-
Evaluation of brain tumors using dynamic 11C-methionine-PET.J Neurooncol. 2012 Aug;109(1):115-22. doi: 10.1007/s11060-012-0873-9. Epub 2012 Apr 22. J Neurooncol. 2012. PMID: 22528799
-
Demography, Pattern of Care, and Survival in Patients with Xanthoastrocytoma: A Systematic Review and Individual Patient Data Analysis of 325 Cases.J Neurosci Rural Pract. 2019 Jul;10(3):430-437. doi: 10.1055/s-0039-1697873. Epub 2019 Oct 7. J Neurosci Rural Pract. 2019. PMID: 31595115 Free PMC article.
References
-
- Kepes JJ, Rubinstein LJ, Eng LF. Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer 1979;44:1839-1852 - PubMed
-
- Tonn JC, Paulus W, Warmuth Metz M, Schachenmayr W, Sorensen N, Roosen K. Pleomorphic xanthoastrocytoma: Report of six cases with special consideration of diagnostic and therapeutic pitfalls. Surg Neurol 1997;47:162-169 - PubMed
-
- Rippe DJ, Boyko OB, Radi M, Worth R, Fuller GN. MRI of temporal lobe pleomorphic xanthoastrocytoma. J Comput Assist Tomogr 1992;16:856-859 - PubMed
-
- Tien RD, Cardenas CA, Rajagopalan S. Pleomorphic xanthoastrocytoma of the brain: MR findings in six patients. AJR Am J Roentgenol 1992;159:1287-1290 - PubMed
-
- Mascalchi M, Muscas GC, Galli C, Bartolozzi C. MRI of pleomorphic xanthoastrocytoma: Case report. Neuroradiology 1994;36:446-447 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous